S100A9 and early-onset autosomal dominant Alzheimer disease: The same observation was noted in association with Alzheimer’s disease, where a high concentration of S100A9 resulted in the impaired mobility and proliferation of immune cells, indicating neurotoxicity during acute inflammatory conditions [76].